UAE Becomes Second Country to Approve Guselkumab for Crohn's Disease Treatment
The Emirates Drug Establishment (EDE) has approved new indications for Guselkumab, marking the UAE as only the second country globally to authorise its use in treating Crohn's disease.
This move significantly expands treatment options for patients with chronic inflammatory bowel disorders, particularly those unresponsive to current therapies. Guselkumab has shown strong clinical results in managing symptoms and improving outcomes for individuals living with inflammatory bowel disease.
Dr. Fatima Al Kaabi, Director-General of the EDE, said the decision reflects the UAE's proactive healthcare strategy. 'With new indications for Guselkumab being approved, we see the impact of the UAE's forward-looking policies in accelerating access to innovative therapies and enhancing pharmaceutical security,'
she stated.
The approval stems from a rigorous evaluation of global clinical data, confirming Guselkumab's potential in tackling treatment-resistant Crohn's cases. It also aligns with the UAE's broader goal of ensuring rapid access to cutting-edge medical solutions through precision-driven regulatory processes and global partnerships. 'Our fast-track framework, supported by advanced technologies and strong collaboration with international pharmaceutical companies, has helped streamline reviews without compromising safety or efficacy,'
Al Kaabi added.
This milestone further underscores the UAE's role as a regional and global leader in healthcare innovation. The EDE's commitment to modernising regulatory systems ensures that patients across the country have timely access to the latest treatments, reinforcing the nation's position as a trusted hub for advanced medical solutions.
News Source: Emirates News Agency
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hi Dubai
2 days ago
- Hi Dubai
UAE Enforces Midday Break to Protect Outdoor Workers Starting June 15
The UAE's Ministry of Human Resources and Emiratisation (MoHRE) has confirmed the return of the annual Midday Break, banning outdoor work between 12:30 pm and 3:00 pm from 15 June to 15 September 2025. Now in its 21st year, the regulation aims to safeguard workers from heat-related health risks during peak summer temperatures. The Midday Break aligns with the UAE's commitment to international occupational safety standards and sustainable labour practices. It mandates employers to provide shaded rest areas, cooling equipment, drinking water, and first-aid supplies to workers during the restricted hours. 'This initiative reflects the UAE's deeply rooted social and humanitarian values,' said Mohsin Ali Al Nassi, Assistant Undersecretary for Inspection & Compliance at MoHRE. 'With over 99% compliance in recent years, the private sector continues to demonstrate strong awareness of worker welfare.' Dalal Alshehhi, Acting Assistant Undersecretary for Labour Protection, praised the private sector's efforts, noting that many companies now offer fully equipped rest facilities. 'The Midday Break is a model of cooperation between government, businesses, and the wider community,' she said. Certain essential or technically sensitive jobs—such as infrastructure repairs or tasks requiring uninterrupted execution—are exempt from the rule but still require permits and adherence to safety measures. To ensure compliance, MoHRE will carry out inspections and field visits while encouraging the public to report violations. Offenders face fines of AED5,000 per worker, up to AED50,000 for multiple breaches. The Midday Break continues to play a vital role in protecting the UAE's diverse workforce and promoting a safe, responsible work environment during the harsh summer months. News Source: Emirates News Agency
Gulf Today
4 days ago
- Gulf Today
Erth Zayed Philanthropies donates Dhs25m to NMSS
The National Multiple Sclerosis Society (NMSS) has signed a strategic agreement with Erth Zayed Philanthropies to advance its national multiple sclerosis (MS) agenda. As part of this agreement, Erth Zayed Philanthropies will contribute Dhs25 million to support NMSS in delivering its core priorities, including advancing UAE's first National Coalition for MS, a multi-sector platform to improve care, research, and inclusion across the country. The agreement was signed by Dr. Fatima Al Kaabi, Vice Chair of the National Multiple Sclerosis Society, and a representative from Erth Zayed Philanthropies during a formal ceremony in Abu Dhabi. The announcement of this strategic agreement coincides with World MS Day, marked this year under the global theme 'My MS Diagnosis: Navigating MS Together,' which highlights the importance of early detection and community support. This year, Erth Zayed Philanthropies joins the National Coalition for MS as a founding partner, marking a pivotal step in the UAE's efforts to advance equitable MS care and inclusion. This strategic partnership reinforces the UAE's commitment to enhancing MS care, accelerating research, and advancing equity, catalysing broader multi-sector engagement to shape a more inclusive and transformative national response. Coalition members include Sanofi, Axios International, PureHealth and Manzil Healthcare Services, each playing a vital role in advancing care, awareness, and system-wide impact. Dr. Fatima Al Kaabi said, 'The establishment of the National Coalition for MS is a defining step in our mission to drive equitable access to MS care. This work is inspired by the legacy of our Founding Father, the late Sheikh Zayed bin Sultan Al Nahyan, whose vision was rooted in dignity, inclusion, and access to quality care for all. It is sustained by the leadership of President His Highness Sheikh Mohamed Bin Zayed Al Nahyan, whose commitment continues to shape the future of health and reinforce the UAE's position as a global leader in innovative, people-centered healthcare.' 'On World MS Day, we are proud to join the international community, not only in raising awareness, but in taking meaningful, coordinated action that has the potential to transform outcomes for people living with MS. Today, we are laying the foundations for long-term impact rooted in compassion, powered by collaboration, and guided by a shared responsibility to ensure that every member of our community has the opportunity to live a full and dignified life.' WAM
Al Etihad
6 days ago
- Al Etihad
NMSS, Erth Zayed Philanthropies sign Dh25 million grant agreement to mark "World MS Day"
30 May 2025 18:10 ABU DHABI (ALETIHAD)The National Multiple Sclerosis Society (NMSS) has signed a strategic agreement with Erth Zayed Philanthropies to advance its national multiple sclerosis (MS) agenda. As part of this agreement, Erth Zayed Philanthropies will contribute Dh 25 million to support NMSS in delivering its core priorities, including advancing UAE's first National Coalition for MS, a multi-sector platform to improve care, research, and inclusion across the agreement was signed by Dr. Fatima Al Kaabi, Vice Chair of the National Multiple Sclerosis Society, and a representative from Erth Zayed Philanthropies during a formal ceremony in Abu announcement of this strategic agreement coincides with World MS Day, marked this year under the global theme 'My MS Diagnosis: Navigating MS Together,' which highlights the importance of early detection and community year, Erth Zayed Philanthropies joins the National Coalition for MS as a founding partner, marking a pivotal step in the UAE's efforts to advance equitable MS care and inclusion. This strategic partnership reinforces the UAE's commitment to enhancing MS care, accelerating research, and advancing equity, catalyzing broader multi-sector engagement to shape a more inclusive and transformative national response. Coalition members include Sanofi, Axios International, PureHealth and Manzil Healthcare Services, each playing a vital role in advancing care, awareness, and system-wide Fatima Al Kaabi, Vice Chair of NMSS, said: 'The establishment of the National Coalition for MS is a defining step in our mission to drive equitable access to MS care." She added, "This work is inspired by the legacy of our late Founding Father, Sheikh Zayed bin Sultan Al Nahyan, whose vision was rooted in dignity, inclusion, and access to quality care for all. It is sustained by the leadership of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, whose commitment continues to shape the future of health and reinforce the UAE's position as a global leader in innovative, people-centred healthcare."She stated: 'On World MS Day, we are proud to join the international community, not only in raising awareness, but in taking meaningful, coordinated action that has the potential to transform outcomes for people living with MS. Today, we are laying the foundations for long-term impact rooted in compassion, powered by collaboration, and guided by a shared responsibility to ensure that every member of our community has the opportunity to live a full and dignified life.'The grant from Erth Zayed Philanthropies aims to directly support NMSS in delivering on its key priorities and enabling the National Coalition for MS to address the most pressing challenges faced by people living with MS in the the National Coalition for MS was convened by NMSS to bring together government entities, healthcare providers, insurance and pharmaceutical companies, and educational institutions under a unified national agenda for MS. The Coalition's priorities for 2025-2026 are focused on improving access to patient support resources, promoting inclusive workplace policies, strengthening the skills of healthcare professionals through specialised training, increasing public understanding of MS to enable earlier diagnosis, and ensuring long-term sustainability through coordinated fundraising and investment in priorities form an action-oriented framework designed to mobilise resources, strengthen inclusion across sectors, and ensure that the UAE is a world leader in MS care. As the Coalition moves into its implementation phase, its priorities will continue to be shaped by the voices and experiences of the MS community, ensuring that their needs, priorities, and aspirations drive every step of the in shared responsibility and measurable impact, the Coalition's members are onboarded to lead or contribute to key initiatives, with defined commitments that span one to two years depending on the scope of Coalition's priorities reflect a commitment to evidence-based solutions. Since its establishment, NMSS has invested Dh 6.5 million in MS research, with the next NMSS research grant cycle set to launch on June 23, 2025. As the Coalition transitions into its implementation phase, NMSS continues to call on stakeholders across sectors, from policymakers and healthcare institutions to academic bodies and donors, to join this pivotal movement. Source: Aletihad - Abu Dhabi
